23 March 2020 – The registration for the second conference of the International Consortium for Personalised Medicine (ICPerMed) 'Personalised Medicine – From Vision to Practice' is now open. The conference will take place in Paris, France, at La Maison de la Chimie on October 15-16, 2020, and will demonstrate how personalised medicine will lead to the next generation of healthcare by 2030.
Supported by the European Commission, the conference will bring together world’s leading researchers, ELSI experts, health economists, payers, patients and industry representatives, regulatory authorities and HTA experts and ICPerMed members including ministries representatives, research funding and policy organisations.
Within the last years, ICPerMed gathered and analysed needs from relevant stakeholders, defining challenges and actionable levers. In this context, ICPerMed developed a Vision Paper focusing on five challenges or perspectives in personalised medicine:
- Citizen engagement,
- Involvement of health providers,
- Implementation within healthcare systems,
- Health-related information,
- Economic value of implementation.
In the Vision Paper, ICPerMed provides keys on how to cross personalised medicine barriers through essential and transversal pillars that will allow improved therapy, diagnostic and preventive approaches, as well as new healthcare concepts for the benefit of citizens and patients.
During the conference, ICPerMed will be committed to demonstrate the importance and the need to address personalised medicine challenges through the prism of these critical pillars focusing on data & technology, intersectoral synergies and education & literacy necessary to initiate the translation into healthcare systems. To this end, the conference will comprise keynote lectures focusing on the implementation of personalised medicine approaches into healthcare systems for the benefit of patients, citizens and the society as a whole. In addition, in a specific dedicated session, ICPerMed will feature and honour best practices in personalised medicine research through the ICPerMed Recognition 2020, that aims to recognise, encourage, promote and disseminate outstanding examples.
For further information about the conference, please contact ICPerMed@agencerecherche.fr